News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
681,273 Results
Type
Article (39131)
Company Profile (270)
Press Release (641872)
Section
Business (204369)
Career Advice (1990)
Deals (35454)
Drug Delivery (80)
Drug Development (80779)
Employer Resources (167)
FDA (16025)
Job Trends (14832)
News (344833)
Policy (32516)
Tag
Academia (2546)
Africa (713)
Alliances (49300)
Alzheimer's disease (1143)
Approvals (15956)
Arizona (173)
Artificial intelligence (66)
Asia (36972)
Australia (6026)
Bankruptcy (352)
Best Places to Work (11275)
Biosimilars (63)
Biotechnology (189)
C2C Services and Suppliers (79046)
California (1769)
Canada (899)
Cancer (388)
Career advice (1659)
Cell therapy (113)
China (135)
Clinical research (63193)
Collaboration (127)
Colorado (70)
Compensation (71)
Connecticut (68)
COVID-19 (2497)
Cystic fibrosis (72)
Data (223)
Diabetes (80)
Diagnostics (5981)
Drug pricing (63)
Earnings (83760)
Employer resources (142)
Europe (79008)
Events (108169)
Executive appointments (132)
FDA (16221)
Florida (251)
Funding (131)
Gene therapy (87)
GLP-1 (509)
Government (4300)
Healthcare (18617)
Hotbed/Location (482651)
Illinois (248)
Indiana (142)
Infectious disease (2523)
Inflammatory bowel disease (91)
Interviews (306)
IPO (16215)
Job creations (3653)
Job search strategy (1424)
Kansas (95)
Layoffs (397)
Legal (7862)
Lung cancer (90)
Manufacturing (81)
Maryland (370)
Massachusetts (1443)
Medical device (13036)
Medtech (13041)
Mergers & acquisitions (19077)
Metabolic disorders (240)
Michigan (122)
Minnesota (210)
Neuroscience (1275)
New Jersey (532)
New York (558)
NextGen Class of 2024 (6514)
Non-profit (4466)
North Carolina (578)
Northern California (785)
Obesity (143)
Ohio (104)
Opinion (175)
Patents (65)
Pennsylvania (561)
People (56108)
Pharmaceutical (63)
Phase I (19593)
Phase II (27834)
Phase III (20793)
Pipeline (103)
Postmarket research (2547)
Preclinical (8336)
Press Release (64)
Rare diseases (125)
Real estate (5926)
Recruiting (63)
Regulatory (21224)
Research institute (2310)
Resumes & cover letters (347)
South America (1087)
Southern California (713)
Startups (3609)
Texas (223)
United States (8135)
Vaccines (463)
Washington State (243)
Weight loss (124)
Date
Today (131)
Last 7 days (609)
Last 30 days (2237)
Last 365 days (37332)
2024 (25627)
2023 (40177)
2022 (51287)
2021 (55837)
2020 (54158)
2019 (46644)
2018 (35125)
2017 (32224)
2016 (31629)
2015 (37706)
2014 (31456)
2013 (26500)
2012 (28770)
2011 (29426)
2010 (27525)
681,273 Results for "trellis bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Octave® Bioscience, Inc. Announces Publication in Nature Communications
Octave ® Bioscience, Inc. today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications.
May 29, 2024
·
5 min read
Business
Xenetic Biosciences, Inc. Announces Executive Leadership Transition
Xenetic Biosciences, Inc. today announced the appointment of James Parslow, the Company’s Chief Financial Officer, as interim Chief Executive Officer, effective May 16, 2024.
May 22, 2024
·
5 min read
Biotech Beach
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock - June 14, 2024
Avidity Biosciences, Inc. announced the pricing of an underwritten public offering of 10,550,000 shares of its common stock at a price to the public of $38.00 per share.
June 13, 2024
·
5 min read
Deals
Pulse Biosciences, Inc. Announces Commencement of Rights Offering - June 4, 2024
Pulse Biosciences, Inc. today announced that it has commenced its previously announced rights offering of up to $60,000,000 of units (the “Units,” and each, a “Unit”) at the Initial Price (as defined below).
June 4, 2024
·
7 min read
Genetown
Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET
Pressure BioSciences, Inc. announced that the Company will host a teleconference to update investors and other stakeholders in the Company on a number of business and financial topics.
June 13, 2024
·
4 min read
Genetown
Pressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ET
Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” and the “Company”) today announced that the Company will host a teleconference to update investors and other stakeholders in the Company on a number of business and financial topics.
June 18, 2024
·
4 min read
Drug Development
Trellis Bioscience Announces Positive Interim Phase 1 Results for TRL1068, a Novel Native Human Monoclonal Antibody Which Reduces Bacterial Biofilm Burden in Chronic Prosthetic Joint Infections
Trellis Bioscience Inc announced a clinical proof-of-concept milestone from a planned interim analysis of the company’s Phase 1 trial of its lead antibody, TRL1068, in patients with prosthetic joint infections.
May 4, 2023
·
7 min read
Biotech Beach
Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock - June 12, 2024
Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, announced that it intends to offer and sell, subject to market and other conditions, $300.0 million of shares of its common stock in an underwritten public offering.
June 12, 2024
·
5 min read
Business
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Xenetic Biosciences, Inc. today reported its financial results for the first quarter of 2024 and provided a business update.
May 10, 2024
·
6 min read
Genetown
Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024
Harvard Bioscience, Inc. announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriott Marquis in New York City on June 5, 2024.
May 23, 2024
·
1 min read
1 of 68,128
Next
